The Nifty 50 is facing a critical support test at the 23,000 level following seven consecutive weeks of market declines. Technical indicators show persistent weakness, while the banking sector, including major lenders like HDFC Bank, continues to grapple with structural hurdles.
The Nifty 50 index has entered a challenging phase, approaching the key support level of 23,000 after seven straight weeks of losses. This is the longest streak of weekly declines for the index since the pandemic-driven market correction in 2020. Market sentiment remains cautious, with technical indicators showing that the index is trading below its 50-day and 100-day average prices. These levels often serve as a gauge for medium-term trends, and the current position suggests the market is under pressure.
Investors are keeping a close watch on the 23,270 to 23,300 range. If the index fails to move above this resistance zone, technical analysts note that the selling pressure may continue, potentially pushing the index toward support levels near 22,800 and 22,600. The momentum indicators, which measure the speed and change of price movements, are currently in a bearish range, reflecting a lack of immediate buying interest.
The banking sector is also navigating a difficult period. The Bank Nifty index, which has recorded five weeks of losses, is currently testing a significant support level at 55,000. This level is considered vital for the sector's stability. HDFC Bank, a major component of this index, continues to trade below its key averages, and without a clear signal of trend reversal, the sector remains vulnerable. Any drop below the 55,000 mark could increase volatility, with market participants looking at 54,400 as a potential next area of interest.
While the overall market sentiment is weak, some individual stocks are showing different trends. Jubilant Pharmova has attracted attention due to its relative strength against the benchmark, with its price pattern breaking out of a horizontal trend. Similarly, Privi Speciality Chemicals has shown positive movement after breaking out from a recent phase of stable pricing, with momentum indicators suggesting the potential for further activity. Zydus Lifesciences is also being observed for its positioning near its 100-day moving average, which is often monitored as a floor for price support.
However, investors are also exercising caution with other stocks. For example, Welspun Corp has shown a divergence between its price action and its momentum indicators. This pattern, where the stock price rises while the momentum slows, often indicates that a stock may be overstretched, suggesting that profit-taking could occur even if the broader trend remains in place.
The immediate monitorable for investors remains the 23,000 support level on the Nifty and the 55,000 level on the Bank Nifty. Whether these indices hold these levels or break below them will likely determine the market trajectory in the coming sessions.